Neuromuscular blocking agents in the intensive care unit [PDF]
Journal of International Medical Research, 2022 Neuromuscular blocking agents (NMBA) are a controversial therapeutic option in the approach to the critically ill patient. They are not innocuous, and the available evidence does not support their routine use in the intensive care unit.
Jonathan Rodríguez-Blanco +7 more
doaj +2 more sources
Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study [PDF]
Perioperative MedicineBackground Residual neuromuscular blockade (rNMB) remains a persistent and preventable problem, with serious risks. Methods Our objective was to describe and assess patterns in the use of neuromuscular blocking agents (NMBAs), neuromuscular transmission (
Piet Krijtenburg +5 more
doaj +2 more sources
Association Between Intermediate-Acting Neuromuscular-Blocking Agents and Short-Term Postoperative Outcomes in Patients with Gastric Cancer [PDF]
Cancer Management and Research, 2020 Lingxia Niu,1,* Chunlin Yao,1,* Yu Wang,1 Yan Sun,1 Juan Xu,2 Yun Lin,1 Shanglong Yao1 1Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, People’s Republic of ...
Niu L +6 more
doaj +2 more sources
Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents [PDF]
JA Clinical Reports, 2019 Michiko Higashi +2 more
doaj +2 more sources
Use of Dexmedetomidine as an Adjuvant to Propofol along with Neurophysiological Monitoring of the Seventh Cranial Nerve during Cerebello- Pontine Tumour Excision Surgery [PDF]
Journal of Clinical and Diagnostic Research, 2021 Cerebello‑Pontine Angle (CPA) surgeries are very challenging for neurosurgeons as it lies very close to brain stem so various cranial nerves are at risk of damage. Generally, such surgeries require neuromuscular monitoring of various cranial nerves. For
POOJA ARPAN SHAH +2 more
doaj +1 more source
Pharmacodynamic interactions between muscle relaxants and other medications in practice of anesthesia [PDF]
Farmacja Polska, 2023 Knowledge of drug interactions is an essential element of medical practice. Along with the increasing occurrence of multimorbidity and the associated multi-drug use, the number of possible combinations of preparations is constantly rising.
Paweł Radkowski, Rafał Marek Okoński
doaj +1 more source
Neuromuscular block in patients 80 years and older: a prospective, controlled study
BMC Anesthesiology, 2021 Background An increasing number of patients older than 80 years are undergoing anesthesia, but little information is available regarding pharmacodynamic effects of myorelaxants in this population.
Denis Schmartz +4 more
doaj +1 more source
Current use of neuromuscular blocking agents and antagonists in Korea: a 2018 survey. [PDF]
Anesth Pain Med (Seoul), 2019 Kim JS +8 more
europepmc +3 more sources
ROCURONIUM BROMIDE – ESMERON [PDF]
, 2023 Repeated neuromuscular-blocking agent administration lengthens the duration of action, and intraoperative use of high doses of neuromuscular-blocking agent may compromise respiratory security.
Ibraimi, Qahil +2 more
core +2 more sources
Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study [PDF]
, 2012 Objective: To determine whether use of intermediate acting neuromuscular blocking agents during general anesthesia increases the incidence of postoperative respiratory complications. Design: Prospective, propensity score matched cohort study.
Bateman, Brian Thomas +9 more
core +1 more source